Tatsuki Fukami

7.9k total citations · 1 hit paper
225 papers, 6.4k citations indexed

About

Tatsuki Fukami is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Tatsuki Fukami has authored 225 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pharmacology, 68 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Tatsuki Fukami's work include Pharmacogenetics and Drug Metabolism (62 papers), Drug Transport and Resistance Mechanisms (40 papers) and Drug-Induced Hepatotoxicity and Protection (39 papers). Tatsuki Fukami is often cited by papers focused on Pharmacogenetics and Drug Metabolism (62 papers), Drug Transport and Resistance Mechanisms (40 papers) and Drug-Induced Hepatotoxicity and Protection (39 papers). Tatsuki Fukami collaborates with scholars based in Japan, United States and China. Tatsuki Fukami's co-authors include Miki Nakajima, Tsuyoshi Yokoi, Koichi Tsuneyama, Yasuhiro Aoki, Shingo Oda, Masataka Takamiya, Masataka Nakano, Howard L. McLeod, Yuki Kobayashi and M. Ihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Physical review. B, Condensed matter.

In The Last Decade

Tatsuki Fukami

218 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

1994 517 citations Tatsuki Fukami et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tatsuki Fukami Japan	42	2.4k	2.1k	1.3k	884	800	225	6.4k
Neil R. Kitteringham United Kingdom	47	3.1k 1.3×	1.8k 0.9×	937 0.7×	372 0.4×	504 0.6×	92	7.3k
Ute Hofmann Germany	45	1.7k 0.7×	1.6k 0.8×	1.9k 1.4×	549 0.6×	544 0.7×	183	6.3k
Edward T. Morgan United States	46	2.3k 0.9×	3.7k 1.8×	2.0k 1.5×	386 0.4×	679 0.8×	120	7.7k
Jürgen Borlak Germany	49	3.8k 1.6×	1.6k 0.8×	1.0k 0.8×	1.4k 1.5×	889 1.1×	201	8.7k
Caroline F. Thorn United States	35	2.2k 0.9×	2.0k 1.0×	1.3k 1.0×	445 0.5×	252 0.3×	58	6.9k
James T. Dalton United States	55	3.4k 1.4×	547 0.3×	1.4k 1.0×	520 0.6×	1.0k 1.3×	203	9.6k
Shufeng Zhou China	34	2.3k 1.0×	1.2k 0.6×	913 0.7×	370 0.4×	323 0.4×	112	5.2k
Kathrin Klein Germany	44	1.8k 0.7×	3.6k 1.8×	2.9k 2.2×	466 0.5×	276 0.3×	112	7.7k
Joo‐Youn Cho South Korea	40	1.6k 0.7×	1.1k 0.5×	1.3k 1.0×	230 0.3×	482 0.6×	289	5.8k
Ryuichi Kato Japan	48	3.1k 1.3×	2.9k 1.4×	1.1k 0.8×	1.3k 1.5×	1.1k 1.4×	354	8.9k

Countries citing papers authored by Tatsuki Fukami

Since Specialization

Citations

This map shows the geographic impact of Tatsuki Fukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuki Fukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuki Fukami more than expected).

Fields of papers citing papers by Tatsuki Fukami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuki Fukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuki Fukami. The network helps show where Tatsuki Fukami may publish in the future.

Co-authorship network of co-authors of Tatsuki Fukami

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuki Fukami. A scholar is included among the top collaborators of Tatsuki Fukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuki Fukami. Tatsuki Fukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakano, Masataka, et al.. (2025). Cigarette smoking modulates m6A modification, affecting the induction of CYP1A1 mRNA by regulating human ARNT and AHRR in A549 cells. Toxicology Letters. 407. 41–49.

Nakano, Masataka, Masato Tomii, Yuichiro Higuchi, et al.. (2025). Switch/sucrose non-fermentable complex interacts with constitutive androstane receptor to regulate drug-metabolizing enzymes and transporters in the liver. Drug Metabolism and Disposition. 53(4). 100057–100057.

Fukami, Tatsuki, Takashi Kudo, Masataka Nakano, et al.. (2024). Iminium ion metabolites are formed from nintedanib by human CYP3A4. Drug Metabolism and Pharmacokinetics. 57. 101025–101025.

Hayashi, Shun, Hiroko Kawaguchi, Takao Watanabe, et al.. (2023). Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver. Xenobiotica. 53(4). 241–247. 2 indexed citations

Fukami, Tatsuki, Naoki Ishiguro, Wataru Kishimoto, et al.. (2023). Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine. Drug Metabolism and Disposition. 51(12). 1569–1577. 5 indexed citations

Shimizu, Mai, et al.. (2023). Utility of a Systematic Approach to Selecting Candidate Prodrugs: A Case Study Using Candesartan Ester Analogues. Journal of Pharmaceutical Sciences. 112(6). 1671–1680. 3 indexed citations

Fukami, Tatsuki, et al.. (2022). Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut Microbiota. Drug Metabolism and Disposition. 50(5). 725–733. 3 indexed citations

Yamanaka, Hiroyuki, et al.. (2021). Evaluation of lens opacity due to inhibition of cholesterol biosynthesis using rat lens explant cultures. Toxicology. 465. 153064–153064. 4 indexed citations

Nakano, Masataka, Tatsuki Fukami, & Miki Nakajima. (2019). Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver–Derived Cells by Attenuating Splicing. Journal of Pharmacology and Experimental Therapeutics. 370(3). 408–415. 6 indexed citations

10.

Nakano, Masataka, et al.. (2018). miR-141-3p commonly regulates human UGT1A isoforms via different mechanisms. Drug Metabolism and Pharmacokinetics. 33(4). 203–210. 13 indexed citations

11.

Fukami, Tatsuki, et al.. (2017). Histologic chorioamnionitis prevalence in patients with premature rupture membranes. Clinical and Experimental Obstetrics & Gynecology. 44(2). 236–238. 2 indexed citations

12.

Fukami, Tatsuki, Minako Goto, Hiroaki Yamamoto, et al.. (2017). The relation between causes and onset time of polyhydramnios. Clinical and Experimental Obstetrics & Gynecology. 44(1). 113–115. 1 indexed citations

13.

Tang, Seng Chuan, Rolf W. Sparidans, Tatsuki Fukami, et al.. (2014). P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the mTOR Inhibitor Everolimus (Afinitor) in Mice. Clinical Cancer Research. 20(12). 3133–3145. 31 indexed citations

14.

Fukami, Tatsuki & Tsuyoshi Yokoi. (2012). The Emerging Role of Human Esterases. Drug Metabolism and Pharmacokinetics. 27(5). 466–477. 189 indexed citations

15.

Akai, S., et al.. (2009). An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and γ-glutamylcysteine synthetase knockdown cells. Toxicology in Vitro. 24(3). 1032–1038. 35 indexed citations

16.

Morita, Mayu, et al.. (2009). Knockdown of superoxide dismutase 2 enhances acetaminophen-induced hepatotoxicity in rat. Toxicology. 264(1-2). 89–95. 23 indexed citations

17.

Elouadi, Brahim, et al.. (2004). Effects of CaTiO 3 on Electrical Properties in LiTaO 3 Ceramics. Ferroelectrics. 304. 965–968. 1 indexed citations

18.

Fukami, Tatsuki, et al.. (2003). Acute pancreatitis occurring in the early postpartum period: a case report. Journal of Perinatal Medicine. 31(4). 345–9. 1 indexed citations

19.

Yasuda, Takashi, Ryuji Kondo, Shinjiro Takano, Tatsuki Fukami, & Takafumi Aomine. (1996). Interlayer Josephson coupling in BiSrCaCuO single crystals. Physica C Superconductivity. 263(1-4). 416–419. 6 indexed citations

20.

Hafid, M., et al.. (1996). Thermostimulated current, dielectric and epr studies of the paraelectric phase of ni-doped barium-strontium titanate ceramics. Ferroelectrics. 186(1). 173–176. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact